Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.

The biotechnology centre - Menarini Biotech
The ideal partner in co-developing and licensing of biological products

For thirty years Menarini has been a leader in the biotech sector in Italy: commitment that has led to the creation of the biotechnology centre of excellence in Pomezia. Complying with the highest manufacturing standards (cGMPs), Menarini’s research centre has been authorised by the Italian Medicines Agency (Agenzia Italiana del Farmaco - AIFA) to produce pharmaceutical products for clinical use.

Menarini exclusively operates in the pharmaceutical sector and develops biological drugs from the laboratory scale to the pilot scale, up to production on an industrial scale. The perfect partner for the development and production of biological drugs, a valid advisor for every aspect, from drug development up to its registration and marketing.

Menarini Biotech: at the forefront in biotechnology

April 1953: Scientists Watson and Crick identified the double helix structure of DNA. It was a discovery that gave birth to biotechnology, a new science aimed at discovering innovative drugs from living cells. There are many different disciplines involved: molecular biology and biochemistry, and process engineering.

Discover the Menarini Biotech site

Why biotechnology?

Biotechnology drugs are better suited to human physiology than products containing synthetic molecules given that they are extremely selective and accurate in hitting the target. The results include a lower impact of side effects and greater effectiveness of treatment.
Biotechnology uses living organisms (bacterial cells, yeasts, mammalian cells) to produce pharmaceutical products and create substances with pharmacological activities, such as monoclonal antibodies for treating cancer.

Menarini opens new horizons for treatment

Menarini Biotech represents Italian excellence in the research sector of biotech drugs. Menarini's work is patient-centred: to meet the patient's every need it invests in biotechnology research and innovation, the new breakthrough in medicine for drugs that cannot be synthetically reproduced. When synthetics are unsuccessful, biotech is the answer.
  1. Therapy & Wellness

    Therapy and

    Discover all the therapeutic areas where Menarini is present with products marketed in Italy.

    Enter »

  2. Diagnostics


    A. Menarini Diagnostics responds in a concrete, comprehensive and competent manner to diagnostic and preventive medicine investigations.

    Enter »

  3. Biotechnology


    Menarini Biotech represents Italian excellence in research in the field of biologic drugs. Cutting-edge technologies

    Enter »


Concession granted by Italian Ministry for Cultural Heritage and Activities Read more